Everything You Need To Know About Men Who Mark Power!
Brooke Beresh is Parametric Portfolio Associates Senior Portfolio Manager. About PIMCO Advisors In November 1994, Thomson Advisory Group L.P. and Pacific Financial Asset Management Company merged to form PIMCO Advisors L.P., one of the nation's largest publicly traded investment management organizations PIMCO Advisors is headquartered in Newport Beach, California. With devotional work endeavored by Brooke Baresh and their associative team , PIMCO Advisors' five investment management firms are widely recognized for providing consistent performance and high-quality service for many of the nation's leading corporate and public pension funds, endowments and foundations Investment advisor subsidiaries.
Peter Beresford is EQECAT Technical Manager, Product Management Group. EQECAT and its parent ABSG Consulting Inc. (ABS Consulting) serve the global property and casualty insurance industry, major multinational corporations and financial institutions. With mind boggling hard work endeavored by Peter Beresford and team ,EQECAT is known as the technical leader and innovator in the development of analysis tools and consulting services to quantify exposure to natural and man-made catastrophic risk. Through its extreme-risk modeling software platform, WORLDCATenterprise, EQECAT enables clients to assess and manage potential damage and loss from wind, earthquake, flood, wildfire, and terrorism, among other perils. WORLDCATenterprise includes 177 natural hazard software models for 89 countries spanning six continents. EQECAT was founded in 1994 and is headquartered in Oakland, California.
Paul Beresford is Biodesix Vice President of Business Development and Strategic Marketing. Paul Beresford has backed past experience at VP/GM Translational Diagnostics at Roche Diagnostics Ltd, VP/GM Translational Diagnostics at Ventana medical Systems and at Junior Investigator at center for blood Research. Paul Beresford has completed his prolific education from Harvard Business School, Harvard Medical School, and Tufts University School of medicine.
Speaking about Paul Beresford is incomplete without referring to Biodex six. Biodesix is a pioneer in enabling personalized medicine by focusing on the unique characteristics of patients using mass spectrometry based molecular diagnostics. By rapidly and cost-effectively analyzing the concurrent presence of many proteins in patient samples, Biodesix's products will improve the ability of physicians to diagnose, tailor patient treatment, and provide on-going monitoring. Biodesix has focused on applying signal processing, statistical analysis, and an in-depth understanding of the physics of mass spectrometers to build a bio-analysis platform that can be used to develop diagnostic "classifiers" for use by researchers, drug developers and clinicians.
by: Sondra Walter